Spinal pump may ease cancer pain when pills fail
NCT ID NCT05674240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a device that delivers pain medicine directly to the spinal cord for cancer patients with severe pain not controlled by oral opioids. Researchers compared the pump to standard medical management in 30 adults. The goal was to see if the pump reduces pain intensity and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intrathecal Targeted Drug Delivery (Medtronic SynchroMed™ II pump)
- What this could lead to
- If it works, this could offer better pain control and fewer side effects for cancer patients who don't get relief from oral opioids.
- What could go wrong
- This is a small, completed registry study (30 people), not a large trial. The pump requires surgery and carries risks like infection or device problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advocate Aurora Health
Oshkosh, Wisconsin, 54904, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Mind-Body physio program aims to tackle chronic pain and depression together
- Can we decode the different types of pain in multiple sclerosis?
- Can yoga ease the pain of endometriosis after surgery?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Rewiring the brain to fight back pain?